Mahieu Boris, Jacobs Nadia, Mahieu Sarah, Naelaerts Kristine, Vertessen Francine, Weyler Joost, Jacquemyn Yves, Van der Planken Marc
Laboratory of Haemostasis and Haematology, Antwerp University Hospital, Edegem, Belgium.
Blood Coagul Fibrinolysis. 2007 Oct;18(7):685-8. doi: 10.1097/MBC.0b013e3282f09835.
Influence of changes in levels of coagulation factors and anticoagulants on acquired activated protein C (APC) resistance were studied in 40 healthy women during normal pregnancy. Factor VIII (FVIII), von Willebrand factor antigen (VWF:Ag), free protein S (FPS) and protein C were determined at 5-13, 14-26 and 27-40 weeks gestation and more than 6 weeks postpartum. APC anticoagulant activity was determined by measuring the activated partial thromboplastin time before and after adding human APC, expressed as the APC-sensitivity ratio (APC-SR). During the second and third gestation trimesters a significant increase (P < 0.05) in FVIII and VWF:Ag levels and a decrease in FPS levels were seen compared with the first trimester. Postpartum FVIII and VWF:Ag levels significantly decreased and FPS levels increased compared with the third trimester. Protein C levels remained unchanged during pregnancy and postpartum. Between increased FVIII and lowered APC-SR a trend of inverse correlation (r = -0.329; P = 0.076) occurred in the second trimester. No correlation was found between APC-SR and FPS or VWF:Ag levels. A remarkable finding is the strong inverse relationship between APC-SR and protein C levels (r <or= -0.392; P < 0.05) during pregnancy and postpartum. This may indicate that anticoagulant activity of added human APC measured by activated partial thromboplastin time is diminished in the presence of high endogenous protein C levels. A possible hypothesis is steric hindrance by sample protein C of APC binding sites on target activated factor V and/or cofactor protein S. The clinical significance of this finding should be determined because it complicates the interpretation of lowered APC-SR.
在40名正常孕期的健康女性中,研究了凝血因子和抗凝剂水平变化对获得性活化蛋白C(APC)抵抗的影响。在妊娠5 - 13周、14 - 26周、27 - 40周以及产后6周以上,测定了因子VIII(FVIII)、血管性血友病因子抗原(VWF:Ag)、游离蛋白S(FPS)和蛋白C。通过测量加入人APC前后的活化部分凝血活酶时间来测定APC抗凝活性,以APC敏感性比值(APC-SR)表示。与妊娠早期相比,妊娠中期和晚期FVIII和VWF:Ag水平显著升高(P < 0.05),FPS水平降低。与妊娠晚期相比,产后FVIII和VWF:Ag水平显著降低,FPS水平升高。妊娠期间和产后蛋白C水平保持不变。在妊娠中期,FVIII升高与APC-SR降低之间存在负相关趋势(r = -0.329;P = 0.076)。未发现APC-SR与FPS或VWF:Ag水平之间存在相关性。一个显著的发现是,在妊娠期间和产后,APC-SR与蛋白C水平之间存在强烈的负相关(r≤ -0.392;P < 0.05)。这可能表明,在高内源性蛋白C水平存在的情况下,通过活化部分凝血活酶时间测量的加入人APC的抗凝活性会降低。一个可能的假说是,样本蛋白C对靶活化因子V和/或辅因子蛋白S上的APC结合位点存在空间位阻。应确定这一发现的临床意义,因为它使对降低的APC-SR的解释变得复杂。